costs.' Yet the most common reason for hospitalization of the diabetic is foot ulcer or foot infection.
Once a foot ulcer or infection occurs, the risk of lower extremity amputation (LEA) is increasedby a factor of eight, leading to more than 50,000 LEAs yearly in the United States. We know that the leading risk factors for LEA are peripheral vascular disease and neuropathy. For years, we thought that vascular disease was the major enemy. That must not be the case, as both the neuropathy and vascular disease affect both hands and feet in a similar fashion. The difference is that the foot is encased in shoes, traumatized daily, and hidden from view. Poor vision and absent protective sensation often delays recognition of injury or infection in the foot. The hand appears to be protected from these traumas, and is generally the source of life-threatening infection in only the most severely ill individuals.
In the current era of prevention, identification of vascular disease does not appear to affect outcomes, as the vascular surgeon need not intervene until the patient presents with a non-healing ulcer or unremitting pain. Peripheral neuropathy must be the enemy. Several of the papers in this issue support the notion that proactive identification of those at risk, combined with foot-specific patient education and protective footwear, will greatly decrease the risk for diabetic foot ulceration, infection and LEA. How can we enact preventive measures to decrease diabetic foot morbidity?
We need to think from a health systems perspective. My health system is a 560-bed tertiary care hospital with 144 primary care physicians that care for over 2,400 diabetic patients. Your "system" may be a 30-bed general hospital with patients driving two hours for health care. Our problems are more similar than you might think. Every diabetic needs to have his or her blood sugar measured periodically. Every diabetic needs to meet with 704 a dietitian and diabetic educator periodically. If the most likely reason for hospitalization is their feet, we simply need to add feet to the curriculum. Every local community and hospital has a diabetic educator. They simply need to add foot screening and foot-specific education to their ongoing program. Medicare and private health insurance pays for protective footwear. The educator simply has to have a resource physician, be it an orthopaedic surgeon, podiatrist, physiatrist, or internist, to evaluate for therapeutic footwear. When problems arise, someone needs to be receptive on a timely basis. By adapting these simple guidelines, you can develop a diabetic foot-specific health system program for proactively dealing with the burden of the diabetic toot.'
Ten years ago, there was little interest from the orthopaedic community in the problem of the diabetic foot. Mark Siovenkai's work as chair of the AOFAS diabetes committee led to the yearlong AOFAS Diabetes 2000 initiative, spearheaded by Ron Smith and Bob Anderson. The body of work developed during this period has not only highlighted the problem but has led to some of the solutions presented in this issue. It is our desire that this second issue of Foot and Ankle International dedicated to the diabetic foot will serve to stimulate the orthopaedic community to get involved and become part of the solution for a disease that directly and indirectly affects all of us.
